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Familial hyperlipidemia (FH) is an inherited metabolic disorder caused by low-density lipoprotein (LDL) receptor abnormality.
The delayed clearance of serum LDL results in severe hypercholesterolemia, which leads to the accumulation of LDL-derived
cholesterol in skin,tendons, and arterial walls.In homozygousform of the disease, severely atheromatous involvementof the aorta
extending to the coronary ostia is almost always present, and particular surgical strategy is required to prevent atheroembolic
events.
1.CaseReport
A 22-year-old female with homozygous familial hyper-
lipidemia (FH) presented with symptoms of exertional
dyspnea and chest pain. On inspection, the xanthomas
on her elbow and knee were rather evident (Figure 1(a)).
Precordial auscultation revealed a 3/6 holosystolic murmur
over the aortic area, radiating through the neck. The
electrocardiogram demonstrated negative T waves in the
inferior leads with signs of left ventricular hypertrophy.
The levels of low-density lipoprotein (LDL) and high-
density lipoprotein (HDL) cholesterol were measured as
450mg/dL and 48mg/dL, respectively. Although the aortic
valve was structurally normal, aortic transvalvular maximal
gradient was measured as 130mmHg on transthoracic
echocardiogram (TTE). There was also an associating mild
aortic regurgitation. The left ventricular outﬂow tract and
proximal ascending aorta could not be optimally evaluated
on TTE, because of poor image quality. Transesophageal
echocardiogram (TEE), showed the diﬀuse atheromatous
narrowing of the aorta from annular level to the descending
thoracic aorta. On TEE, a calciﬁed atheroma, originating
from the aortic wall about 1cm above the aortic annulus,
was protruding through the aortic lumen. TEE also showed
ad i ﬀuse narrowing of the aorta from annular level to the
descending thoracic aorta (Figure 1(b)). The diameters of
the aorta were measured as 1.1, 1.4, and 1.5cm at the levels
of the aortic annulus, sinotubular junction, and ascending
aorta,respectively,(bodysurfaceareawas1.56m2).Magnetic
resonance angiography conﬁrmed the diﬀuse narrowing of
the entire aorta (Figure 2). Coronary angiograms showed
a critical ostial stenosis of the right coronary artery and
a moderate ostial narrowing of the left main coronary
artery (LMCA) (Figure 3). The patient was referred to
surgery. Aortoplasty with autologous pericardial and dacron
patches, endarterectomy of the protruding atheroma, and
aorto-right coronary artery saphenous bypass grafting were
successfully performed. However, despite the success in the
surgical procedure, the predischarge control transthoracic
echocardiogram performed on the postoperative 10th day
revealed a transaortic maximal gradient of 80mmHg.
2.Discussion
In FH, aortic root is usually the ﬁrst site of involvement in
the processofaccelerated atherosclerosisand resultsin aortic
valvular or supravalvular stenosis. Then, the process extends
into thecoronary ostia [1].InpatientswithhomozygousFH,2 ISRN Cardiology
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Figure 1: Xanthoma on elbow skin in, (a) an atheroma protruding into the aortic lumen in (b) (red star).
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Figure 2: MR angiogram showingdiﬀuse narrowing of the entire aorta.
supravalvular aortic stenosis (AS) occurs in as many as 44%
of cases [2–4] .S u p r a v a l v u l a rA Si sa l s os e e ni nh e t e r o z y g o t e s
with a lower incidence (4 percent in one report) [4].
In surgical procedures of these patients, aggressive aortic
palpation, cross-clamping, cannulation, and “sandblasting”
eﬀect caused by the jet of blood perfusate from the aortic
cannula may cause embolization of atherosclerotic material
from theascending aorta. Ina retrospective study,Sternetal.
[5] showed that aortic endarterectomy in addition to the
coronary artery bypass surgery, resulted in a 3 times higher
intraoperative stroke rate. However, in a prospective study,
Tunick et al. [6] evaluated the risk of vascular events in
patients with protruding aortic atheromas. In this study, 521
patients had TEE (42 had protruding aortic atheromas), and
they were followed for up to 2 years. 33% of patients with
aortic atheromas had vascular events during followup versus
7% of control group.
In our case, both the diﬀuse atherosclerotic narrowing
of the entire aorta extending into the coronary ostia and
the complex (>5mm in diameter) protruding atheroma
were contributing to the symptoms of angina and dysp-
nea. The transaortic maximal gradient was 130mmHg on
continuous wave Doppler examination. Aortoplasty with
autologous pericardial and dacron patches, endarterectomy
of the protruding atheroma, and aorto-right coronary artery
saphenous grafting with proximal anastomosis to the rela-
tively nonatheromatous region of the aorta were performed.
Postoperative neurological course was uneventful. To avoidISRN Cardiology 3
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Figure 3: Critical ostial and mid portion stenosis of the right coronary artery and a moderate ostial stenosis of the LMCA on coronary
angiography.
an iatrogenic aortic valve insuﬃciency, the diameters of
the reconstructed aorta were kept limited. On postoperative
TTE, the transaortic gradient was found to be 80mmHg,
and pressure recovery phenomenon was speculated to be
responsible for this decreased, but still high gradient. Statins
and cholesterol absorption inhibitors have only modest
eﬀects in reducing cholesterol levels in FH [1]. In this
case, the LDL cholesterol level was 450mg/dL despite high-
dose atorvastatin and ezetimibe. Plasmapheresis and liver
transplantation could be eﬀective therapeutic options in
decreasingLDLcholesterollevels.Thepatientwasdischarged
under the treatment of atorvastatin 80mg and ezetimibe
10mg, andduring thefollow-upperiod of3years, therewere
no symptoms or signs consistent with coronary ischemia.
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